maravai lifesciences holdings glp-1 receptor agonist medications Five Unexpected New Uses for Agonists GLP-1: Genetic Variants Related to
Description
Genetic alterations of DPP4 and predisposition to T2DM-associated diseases There are only few studies aiming to identify modifications in the DPP4 gene and their association with T2DM
doi: 10.1038/s41573-025-01231-3, PMID: [DOI] [PubMed] [Google Scholar] 29
Compared to metformin, no significant changes were observed in the LDL cholesterol changes with SGLT2is/metformin (WMD: 0.07
The verdict: Natures Ozempic is marketing
Expression data were normalized to the amount of 18 s rRNA
Restricted studies integrating GLP-1 receptor agonists with alternative anti-obesity pharmaceuticals (e.g., GIP agonists, amylin analogs)
